(Total Views: 423)
Posted On: 09/11/2020 3:07:52 PM
Post# of 653

$RLFTF Tweet from NeuroRX :
Our CEO Dr. Jonathan Javitt recently sat down with @RfwrightLSL of Life Science Leader and a panel of biopharma CEOs including @PeterDiamandis to discuss #COVID19 technologies in development and our work with #RLF100.
Watch the roundtable:
Tweet Link https://twitter.com/NeuroRxPharma/status/1304460978256478209
$RLFTF (related) What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic https://www.lifescienceleader.com/doc/what-s-...demic-0001
New video w/ Javitt. Around to 20 minute mark he starts talking about trial data and their reaction to the early results
At 20:55
"And now we're about a month away from the first, unblinded look, at the Phase 3, randomized control data
Our CEO Dr. Jonathan Javitt recently sat down with @RfwrightLSL of Life Science Leader and a panel of biopharma CEOs including @PeterDiamandis to discuss #COVID19 technologies in development and our work with #RLF100.
Watch the roundtable:
Tweet Link https://twitter.com/NeuroRxPharma/status/1304460978256478209
$RLFTF (related) What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic https://www.lifescienceleader.com/doc/what-s-...demic-0001
New video w/ Javitt. Around to 20 minute mark he starts talking about trial data and their reaction to the early results
At 20:55
"And now we're about a month away from the first, unblinded look, at the Phase 3, randomized control data


$MJ